Mr. Cable represents as outside general counsel a number of private and public companies, where he counsels boards of directors and management teams on corporate governance, mergers and acquisitions, and disclosure and securities law matters.
Representative M&A transactions in the past five years include the sale of Onyx Pharmaceuticals to Amgen ($10.4 billion), the sale of Eloqua to Oracle ($1 billion), the majority sale of Foundation Medicine to Roche ($1 billion), the sale of Idenix to Merck ($3.8 billion), the sale of Pharmacyclics to AbbVie ($21 billion), the sale of Xoom to PayPal ($1 billion), the private company sale of Stemcentrix to Abbvie ($5.8 billion), the sale of Opower to Oracle ($600 million), the acquisition of NXP by Qualcomm ($47 billion), the acquisitions of Euticals ($358 million – Italy) and Gadea ($174 million – Spain) by AMRI, the acquisition of Auspex by Teva Pharmaceuticals ($3.5 billion), the private company acquisition of Cord Blood Registry by AMAG Pharmaceuticals ($700 million), the 2017 sale of Neustar to Golden Gate ($2.9 billion), the 2017 sale of Lionbridge to HIG ($400 million), the 2017 sale of AMRI to Carlyle and GTCR ($1.9 billion), the 2017 sale of PAREXEL to Pamplona ($5 billion), the 2017 cross border sale of inviCRO to Konica Minolta (Japan), and the $4 billion partnership between KIND and Mars. In the course of his career, Mr. Cable has negotiated and executed over 300 M&A transactions.
Mr. Cable also represents public companies in connection with highly confidential “activist” matters, including the successful negotiation of "Cooperation" Agreements with Elliott Management on behalf of Cognizant and Citrix.
Mr. Cable serves regularly as counsel in IPOs (recently representing J.P. Morgan in the cross-border IPO of Trivago), follow-on offerings, and convertible debt transactions including the $1.5 billion convertible debt issuance by Citrix and representing Cornerstone onDemand in the 2017 $300 million strategic PIPE by Silver Lake and Microsoft.
Mr. Cable regularly represents investment banks, including J.P. Morgan, Morgan Stanley, Citibank and Centerview Partners in M&A and Corporate Finance transactions.
Mr. Cable also represents a number of private venture backed life sciences companies in governance, capital formation and collaboration transactions (including Moderna, Rubius and Yumanity).
Mr. Cable serves as a member of the President's Leadership Council at Dartmouth College and as chairman emeritus of the Buckingham Browne & Nichols School. He has also served for more than a decade as a member of the Board of Fellows of Harvard Medical School. Mr. Cable leads the firm’s Pro Bono efforts on behalf of Camp Harbor View, a summer enrichment program for Boston’s youth.